SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

ImageneBio, Inc.
Date: Sept. 11, 2025 · CIK: 0001835579 · Accession: 0000000000-25-009873

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290108

Date
September 11, 2025
Author
Division of
Form
UPLOAD
Company
ImageneBio, Inc.

Letter

Re: ImageneBio, Inc. Registration Statement on Form S-1 Filed September 8, 2025 File No. 333-290108 Dear Kristin Yarema:

September 11, 2025

Kristin Yarema Chief Executive Officer ImageneBio, Inc. 12526 High Bluff Drive, Suite 345 San Diego, CA 92130

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tyler Howes at 202-551-3370 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Asa Henin, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 September 11, 2025

Kristin Yarema
Chief Executive Officer
ImageneBio, Inc.
12526 High Bluff Drive, Suite 345
San Diego, CA 92130

 Re: ImageneBio, Inc.
 Registration Statement on Form S-1
 Filed September 8, 2025
 File No. 333-290108
Dear Kristin Yarema:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Tyler Howes at 202-551-3370 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Asa Henin, Esq.
</TEXT>
</DOCUMENT>